Global Psychedelic Drugs Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 124

Published Date: 10 Jan 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Psychedelic Drugs market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Psychedelic Drugs market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Psychedelic Drugs market size and forecasts, in consumption value ($ Million), 2018-2029
Global Psychedelic Drugs market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Psychedelic Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Psychedelic Drugs market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Psychedelic Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Psychedelic Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include COMPASS Pathways PLC, Pfizer, Eli Lilly, GlaxoSmithKline and Cybin Inc, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
Psychedelic Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Psilocybin
    LSD
    MDMA
    DMT
    Ketamine
    Others

Market segment by Application
    Depressive Disorders
    Post-Traumatic Stress Disorders
    Substance Abuse Disorders
    Obsessive Compulsive Disorders
    Others

Market segment by players, this report covers
    COMPASS Pathways PLC
    Pfizer
    Eli Lilly
    GlaxoSmithKline
    Cybin Inc
    Field Trip Health
    ATAI Life Sciences
    NUMINUS WELLNESS
    MindMed
    HAVN Life Sciences
    Seelos Therapeutics
    Jannsen
    Acadia Pharmaceuticals
    Intellipharmaceutics
    Revive Therapeutics
    Mydecine Innovations Group
    Red Light Holland
    Braxia Scientific
    Mind Cure Health
    Entheon Biomedical

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Psychedelic Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Psychedelic Drugs, with revenue, gross margin and global market share of Psychedelic Drugs from 2018 to 2023.
Chapter 3, the Psychedelic Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Psychedelic Drugs market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Psychedelic Drugs.
Chapter 13, to describe Psychedelic Drugs research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Psychedelic Drugs
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Psychedelic Drugs by Type
        1.3.1 Overview: Global Psychedelic Drugs Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Psychedelic Drugs Consumption Value Market Share by Type in 2022
        1.3.3 Psilocybin
        1.3.4 LSD
        1.3.5 MDMA
        1.3.6 DMT
        1.3.7 Ketamine
        1.3.8 Others
    1.4 Global Psychedelic Drugs Market by Application
        1.4.1 Overview: Global Psychedelic Drugs Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Depressive Disorders
        1.4.3 Post-Traumatic Stress Disorders
        1.4.4 Substance Abuse Disorders
        1.4.5 Obsessive Compulsive Disorders
        1.4.6 Others
    1.5 Global Psychedelic Drugs Market Size & Forecast
    1.6 Global Psychedelic Drugs Market Size and Forecast by Region
        1.6.1 Global Psychedelic Drugs Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Psychedelic Drugs Market Size by Region, (2018-2029)
        1.6.3 North America Psychedelic Drugs Market Size and Prospect (2018-2029)
        1.6.4 Europe Psychedelic Drugs Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Psychedelic Drugs Market Size and Prospect (2018-2029)
        1.6.6 South America Psychedelic Drugs Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Psychedelic Drugs Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 COMPASS Pathways PLC
        2.1.1 COMPASS Pathways PLC Details
        2.1.2 COMPASS Pathways PLC Major Business
        2.1.3 COMPASS Pathways PLC Psychedelic Drugs Product and Solutions
        2.1.4 COMPASS Pathways PLC Psychedelic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 COMPASS Pathways PLC Recent Developments and Future Plans
    2.2 Pfizer
        2.2.1 Pfizer Details
        2.2.2 Pfizer Major Business
        2.2.3 Pfizer Psychedelic Drugs Product and Solutions
        2.2.4 Pfizer Psychedelic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Pfizer Recent Developments and Future Plans
    2.3 Eli Lilly
        2.3.1 Eli Lilly Details
        2.3.2 Eli Lilly Major Business
        2.3.3 Eli Lilly Psychedelic Drugs Product and Solutions
        2.3.4 Eli Lilly Psychedelic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Eli Lilly Recent Developments and Future Plans
    2.4 GlaxoSmithKline
        2.4.1 GlaxoSmithKline Details
        2.4.2 GlaxoSmithKline Major Business
        2.4.3 GlaxoSmithKline Psychedelic Drugs Product and Solutions
        2.4.4 GlaxoSmithKline Psychedelic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 GlaxoSmithKline Recent Developments and Future Plans
    2.5 Cybin Inc
        2.5.1 Cybin Inc Details
        2.5.2 Cybin Inc Major Business
        2.5.3 Cybin Inc Psychedelic Drugs Product and Solutions
        2.5.4 Cybin Inc Psychedelic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Cybin Inc Recent Developments and Future Plans
    2.6 Field Trip Health
        2.6.1 Field Trip Health Details
        2.6.2 Field Trip Health Major Business
        2.6.3 Field Trip Health Psychedelic Drugs Product and Solutions
        2.6.4 Field Trip Health Psychedelic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Field Trip Health Recent Developments and Future Plans
    2.7 ATAI Life Sciences
        2.7.1 ATAI Life Sciences Details
        2.7.2 ATAI Life Sciences Major Business
        2.7.3 ATAI Life Sciences Psychedelic Drugs Product and Solutions
        2.7.4 ATAI Life Sciences Psychedelic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 ATAI Life Sciences Recent Developments and Future Plans
    2.8 NUMINUS WELLNESS
        2.8.1 NUMINUS WELLNESS Details
        2.8.2 NUMINUS WELLNESS Major Business
        2.8.3 NUMINUS WELLNESS Psychedelic Drugs Product and Solutions
        2.8.4 NUMINUS WELLNESS Psychedelic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 NUMINUS WELLNESS Recent Developments and Future Plans
    2.9 MindMed
        2.9.1 MindMed Details
        2.9.2 MindMed Major Business
        2.9.3 MindMed Psychedelic Drugs Product and Solutions
        2.9.4 MindMed Psychedelic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 MindMed Recent Developments and Future Plans
    2.10 HAVN Life Sciences
        2.10.1 HAVN Life Sciences Details
        2.10.2 HAVN Life Sciences Major Business
        2.10.3 HAVN Life Sciences Psychedelic Drugs Product and Solutions
        2.10.4 HAVN Life Sciences Psychedelic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 HAVN Life Sciences Recent Developments and Future Plans
    2.11 Seelos Therapeutics
        2.11.1 Seelos Therapeutics Details
        2.11.2 Seelos Therapeutics Major Business
        2.11.3 Seelos Therapeutics Psychedelic Drugs Product and Solutions
        2.11.4 Seelos Therapeutics Psychedelic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Seelos Therapeutics Recent Developments and Future Plans
    2.12 Jannsen
        2.12.1 Jannsen Details
        2.12.2 Jannsen Major Business
        2.12.3 Jannsen Psychedelic Drugs Product and Solutions
        2.12.4 Jannsen Psychedelic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 Jannsen Recent Developments and Future Plans
    2.13 Acadia Pharmaceuticals
        2.13.1 Acadia Pharmaceuticals Details
        2.13.2 Acadia Pharmaceuticals Major Business
        2.13.3 Acadia Pharmaceuticals Psychedelic Drugs Product and Solutions
        2.13.4 Acadia Pharmaceuticals Psychedelic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 Acadia Pharmaceuticals Recent Developments and Future Plans
    2.14 Intellipharmaceutics
        2.14.1 Intellipharmaceutics Details
        2.14.2 Intellipharmaceutics Major Business
        2.14.3 Intellipharmaceutics Psychedelic Drugs Product and Solutions
        2.14.4 Intellipharmaceutics Psychedelic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        2.14.5 Intellipharmaceutics Recent Developments and Future Plans
    2.15 Revive Therapeutics
        2.15.1 Revive Therapeutics Details
        2.15.2 Revive Therapeutics Major Business
        2.15.3 Revive Therapeutics Psychedelic Drugs Product and Solutions
        2.15.4 Revive Therapeutics Psychedelic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        2.15.5 Revive Therapeutics Recent Developments and Future Plans
    2.16 Mydecine Innovations Group
        2.16.1 Mydecine Innovations Group Details
        2.16.2 Mydecine Innovations Group Major Business
        2.16.3 Mydecine Innovations Group Psychedelic Drugs Product and Solutions
        2.16.4 Mydecine Innovations Group Psychedelic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        2.16.5 Mydecine Innovations Group Recent Developments and Future Plans
    2.17 Red Light Holland
        2.17.1 Red Light Holland Details
        2.17.2 Red Light Holland Major Business
        2.17.3 Red Light Holland Psychedelic Drugs Product and Solutions
        2.17.4 Red Light Holland Psychedelic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        2.17.5 Red Light Holland Recent Developments and Future Plans
    2.18 Braxia Scientific
        2.18.1 Braxia Scientific Details
        2.18.2 Braxia Scientific Major Business
        2.18.3 Braxia Scientific Psychedelic Drugs Product and Solutions
        2.18.4 Braxia Scientific Psychedelic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        2.18.5 Braxia Scientific Recent Developments and Future Plans
    2.19 Mind Cure Health
        2.19.1 Mind Cure Health Details
        2.19.2 Mind Cure Health Major Business
        2.19.3 Mind Cure Health Psychedelic Drugs Product and Solutions
        2.19.4 Mind Cure Health Psychedelic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        2.19.5 Mind Cure Health Recent Developments and Future Plans
    2.20 Entheon Biomedical
        2.20.1 Entheon Biomedical Details
        2.20.2 Entheon Biomedical Major Business
        2.20.3 Entheon Biomedical Psychedelic Drugs Product and Solutions
        2.20.4 Entheon Biomedical Psychedelic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        2.20.5 Entheon Biomedical Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Psychedelic Drugs Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Psychedelic Drugs by Company Revenue
        3.2.2 Top 3 Psychedelic Drugs Players Market Share in 2022
        3.2.3 Top 6 Psychedelic Drugs Players Market Share in 2022
    3.3 Psychedelic Drugs Market: Overall Company Footprint Analysis
        3.3.1 Psychedelic Drugs Market: Region Footprint
        3.3.2 Psychedelic Drugs Market: Company Product Type Footprint
        3.3.3 Psychedelic Drugs Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Psychedelic Drugs Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Psychedelic Drugs Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global Psychedelic Drugs Consumption Value Market Share by Application (2018-2023)
    5.2 Global Psychedelic Drugs Market Forecast by Application (2024-2029)

6 North America
    6.1 North America Psychedelic Drugs Consumption Value by Type (2018-2029)
    6.2 North America Psychedelic Drugs Consumption Value by Application (2018-2029)
    6.3 North America Psychedelic Drugs Market Size by Country
        6.3.1 North America Psychedelic Drugs Consumption Value by Country (2018-2029)
        6.3.2 United States Psychedelic Drugs Market Size and Forecast (2018-2029)
        6.3.3 Canada Psychedelic Drugs Market Size and Forecast (2018-2029)
        6.3.4 Mexico Psychedelic Drugs Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe Psychedelic Drugs Consumption Value by Type (2018-2029)
    7.2 Europe Psychedelic Drugs Consumption Value by Application (2018-2029)
    7.3 Europe Psychedelic Drugs Market Size by Country
        7.3.1 Europe Psychedelic Drugs Consumption Value by Country (2018-2029)
        7.3.2 Germany Psychedelic Drugs Market Size and Forecast (2018-2029)
        7.3.3 France Psychedelic Drugs Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Psychedelic Drugs Market Size and Forecast (2018-2029)
        7.3.5 Russia Psychedelic Drugs Market Size and Forecast (2018-2029)
        7.3.6 Italy Psychedelic Drugs Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific Psychedelic Drugs Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Psychedelic Drugs Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Psychedelic Drugs Market Size by Region
        8.3.1 Asia-Pacific Psychedelic Drugs Consumption Value by Region (2018-2029)
        8.3.2 China Psychedelic Drugs Market Size and Forecast (2018-2029)
        8.3.3 Japan Psychedelic Drugs Market Size and Forecast (2018-2029)
        8.3.4 South Korea Psychedelic Drugs Market Size and Forecast (2018-2029)
        8.3.5 India Psychedelic Drugs Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Psychedelic Drugs Market Size and Forecast (2018-2029)
        8.3.7 Australia Psychedelic Drugs Market Size and Forecast (2018-2029)

9 South America
    9.1 South America Psychedelic Drugs Consumption Value by Type (2018-2029)
    9.2 South America Psychedelic Drugs Consumption Value by Application (2018-2029)
    9.3 South America Psychedelic Drugs Market Size by Country
        9.3.1 South America Psychedelic Drugs Consumption Value by Country (2018-2029)
        9.3.2 Brazil Psychedelic Drugs Market Size and Forecast (2018-2029)
        9.3.3 Argentina Psychedelic Drugs Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa Psychedelic Drugs Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Psychedelic Drugs Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Psychedelic Drugs Market Size by Country
        10.3.1 Middle East & Africa Psychedelic Drugs Consumption Value by Country (2018-2029)
        10.3.2 Turkey Psychedelic Drugs Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Psychedelic Drugs Market Size and Forecast (2018-2029)
        10.3.4 UAE Psychedelic Drugs Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 Psychedelic Drugs Market Drivers
    11.2 Psychedelic Drugs Market Restraints
    11.3 Psychedelic Drugs Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
    12.1 Psychedelic Drugs Industry Chain
    12.2 Psychedelic Drugs Upstream Analysis
    12.3 Psychedelic Drugs Midstream Analysis
    12.4 Psychedelic Drugs Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Psychedelic Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Psychedelic Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global Psychedelic Drugs Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global Psychedelic Drugs Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. COMPASS Pathways PLC Company Information, Head Office, and Major Competitors
    Table 6. COMPASS Pathways PLC Major Business
    Table 7. COMPASS Pathways PLC Psychedelic Drugs Product and Solutions
    Table 8. COMPASS Pathways PLC Psychedelic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. COMPASS Pathways PLC Recent Developments and Future Plans
    Table 10. Pfizer Company Information, Head Office, and Major Competitors
    Table 11. Pfizer Major Business
    Table 12. Pfizer Psychedelic Drugs Product and Solutions
    Table 13. Pfizer Psychedelic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. Pfizer Recent Developments and Future Plans
    Table 15. Eli Lilly Company Information, Head Office, and Major Competitors
    Table 16. Eli Lilly Major Business
    Table 17. Eli Lilly Psychedelic Drugs Product and Solutions
    Table 18. Eli Lilly Psychedelic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. Eli Lilly Recent Developments and Future Plans
    Table 20. GlaxoSmithKline Company Information, Head Office, and Major Competitors
    Table 21. GlaxoSmithKline Major Business
    Table 22. GlaxoSmithKline Psychedelic Drugs Product and Solutions
    Table 23. GlaxoSmithKline Psychedelic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. GlaxoSmithKline Recent Developments and Future Plans
    Table 25. Cybin Inc Company Information, Head Office, and Major Competitors
    Table 26. Cybin Inc Major Business
    Table 27. Cybin Inc Psychedelic Drugs Product and Solutions
    Table 28. Cybin Inc Psychedelic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. Cybin Inc Recent Developments and Future Plans
    Table 30. Field Trip Health Company Information, Head Office, and Major Competitors
    Table 31. Field Trip Health Major Business
    Table 32. Field Trip Health Psychedelic Drugs Product and Solutions
    Table 33. Field Trip Health Psychedelic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 34. Field Trip Health Recent Developments and Future Plans
    Table 35. ATAI Life Sciences Company Information, Head Office, and Major Competitors
    Table 36. ATAI Life Sciences Major Business
    Table 37. ATAI Life Sciences Psychedelic Drugs Product and Solutions
    Table 38. ATAI Life Sciences Psychedelic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 39. ATAI Life Sciences Recent Developments and Future Plans
    Table 40. NUMINUS WELLNESS Company Information, Head Office, and Major Competitors
    Table 41. NUMINUS WELLNESS Major Business
    Table 42. NUMINUS WELLNESS Psychedelic Drugs Product and Solutions
    Table 43. NUMINUS WELLNESS Psychedelic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 44. NUMINUS WELLNESS Recent Developments and Future Plans
    Table 45. MindMed Company Information, Head Office, and Major Competitors
    Table 46. MindMed Major Business
    Table 47. MindMed Psychedelic Drugs Product and Solutions
    Table 48. MindMed Psychedelic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 49. MindMed Recent Developments and Future Plans
    Table 50. HAVN Life Sciences Company Information, Head Office, and Major Competitors
    Table 51. HAVN Life Sciences Major Business
    Table 52. HAVN Life Sciences Psychedelic Drugs Product and Solutions
    Table 53. HAVN Life Sciences Psychedelic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 54. HAVN Life Sciences Recent Developments and Future Plans
    Table 55. Seelos Therapeutics Company Information, Head Office, and Major Competitors
    Table 56. Seelos Therapeutics Major Business
    Table 57. Seelos Therapeutics Psychedelic Drugs Product and Solutions
    Table 58. Seelos Therapeutics Psychedelic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 59. Seelos Therapeutics Recent Developments and Future Plans
    Table 60. Jannsen Company Information, Head Office, and Major Competitors
    Table 61. Jannsen Major Business
    Table 62. Jannsen Psychedelic Drugs Product and Solutions
    Table 63. Jannsen Psychedelic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 64. Jannsen Recent Developments and Future Plans
    Table 65. Acadia Pharmaceuticals Company Information, Head Office, and Major Competitors
    Table 66. Acadia Pharmaceuticals Major Business
    Table 67. Acadia Pharmaceuticals Psychedelic Drugs Product and Solutions
    Table 68. Acadia Pharmaceuticals Psychedelic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 69. Acadia Pharmaceuticals Recent Developments and Future Plans
    Table 70. Intellipharmaceutics Company Information, Head Office, and Major Competitors
    Table 71. Intellipharmaceutics Major Business
    Table 72. Intellipharmaceutics Psychedelic Drugs Product and Solutions
    Table 73. Intellipharmaceutics Psychedelic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 74. Intellipharmaceutics Recent Developments and Future Plans
    Table 75. Revive Therapeutics Company Information, Head Office, and Major Competitors
    Table 76. Revive Therapeutics Major Business
    Table 77. Revive Therapeutics Psychedelic Drugs Product and Solutions
    Table 78. Revive Therapeutics Psychedelic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 79. Revive Therapeutics Recent Developments and Future Plans
    Table 80. Mydecine Innovations Group Company Information, Head Office, and Major Competitors
    Table 81. Mydecine Innovations Group Major Business
    Table 82. Mydecine Innovations Group Psychedelic Drugs Product and Solutions
    Table 83. Mydecine Innovations Group Psychedelic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 84. Mydecine Innovations Group Recent Developments and Future Plans
    Table 85. Red Light Holland Company Information, Head Office, and Major Competitors
    Table 86. Red Light Holland Major Business
    Table 87. Red Light Holland Psychedelic Drugs Product and Solutions
    Table 88. Red Light Holland Psychedelic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. Red Light Holland Recent Developments and Future Plans
    Table 90. Braxia Scientific Company Information, Head Office, and Major Competitors
    Table 91. Braxia Scientific Major Business
    Table 92. Braxia Scientific Psychedelic Drugs Product and Solutions
    Table 93. Braxia Scientific Psychedelic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 94. Braxia Scientific Recent Developments and Future Plans
    Table 95. Mind Cure Health Company Information, Head Office, and Major Competitors
    Table 96. Mind Cure Health Major Business
    Table 97. Mind Cure Health Psychedelic Drugs Product and Solutions
    Table 98. Mind Cure Health Psychedelic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 99. Mind Cure Health Recent Developments and Future Plans
    Table 100. Entheon Biomedical Company Information, Head Office, and Major Competitors
    Table 101. Entheon Biomedical Major Business
    Table 102. Entheon Biomedical Psychedelic Drugs Product and Solutions
    Table 103. Entheon Biomedical Psychedelic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 104. Entheon Biomedical Recent Developments and Future Plans
    Table 105. Global Psychedelic Drugs Revenue (USD Million) by Players (2018-2023)
    Table 106. Global Psychedelic Drugs Revenue Share by Players (2018-2023)
    Table 107. Breakdown of Psychedelic Drugs by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 108. Market Position of Players in Psychedelic Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 109. Head Office of Key Psychedelic Drugs Players
    Table 110. Psychedelic Drugs Market: Company Product Type Footprint
    Table 111. Psychedelic Drugs Market: Company Product Application Footprint
    Table 112. Psychedelic Drugs New Market Entrants and Barriers to Market Entry
    Table 113. Psychedelic Drugs Mergers, Acquisition, Agreements, and Collaborations
    Table 114. Global Psychedelic Drugs Consumption Value (USD Million) by Type (2018-2023)
    Table 115. Global Psychedelic Drugs Consumption Value Share by Type (2018-2023)
    Table 116. Global Psychedelic Drugs Consumption Value Forecast by Type (2024-2029)
    Table 117. Global Psychedelic Drugs Consumption Value by Application (2018-2023)
    Table 118. Global Psychedelic Drugs Consumption Value Forecast by Application (2024-2029)
    Table 119. North America Psychedelic Drugs Consumption Value by Type (2018-2023) & (USD Million)
    Table 120. North America Psychedelic Drugs Consumption Value by Type (2024-2029) & (USD Million)
    Table 121. North America Psychedelic Drugs Consumption Value by Application (2018-2023) & (USD Million)
    Table 122. North America Psychedelic Drugs Consumption Value by Application (2024-2029) & (USD Million)
    Table 123. North America Psychedelic Drugs Consumption Value by Country (2018-2023) & (USD Million)
    Table 124. North America Psychedelic Drugs Consumption Value by Country (2024-2029) & (USD Million)
    Table 125. Europe Psychedelic Drugs Consumption Value by Type (2018-2023) & (USD Million)
    Table 126. Europe Psychedelic Drugs Consumption Value by Type (2024-2029) & (USD Million)
    Table 127. Europe Psychedelic Drugs Consumption Value by Application (2018-2023) & (USD Million)
    Table 128. Europe Psychedelic Drugs Consumption Value by Application (2024-2029) & (USD Million)
    Table 129. Europe Psychedelic Drugs Consumption Value by Country (2018-2023) & (USD Million)
    Table 130. Europe Psychedelic Drugs Consumption Value by Country (2024-2029) & (USD Million)
    Table 131. Asia-Pacific Psychedelic Drugs Consumption Value by Type (2018-2023) & (USD Million)
    Table 132. Asia-Pacific Psychedelic Drugs Consumption Value by Type (2024-2029) & (USD Million)
    Table 133. Asia-Pacific Psychedelic Drugs Consumption Value by Application (2018-2023) & (USD Million)
    Table 134. Asia-Pacific Psychedelic Drugs Consumption Value by Application (2024-2029) & (USD Million)
    Table 135. Asia-Pacific Psychedelic Drugs Consumption Value by Region (2018-2023) & (USD Million)
    Table 136. Asia-Pacific Psychedelic Drugs Consumption Value by Region (2024-2029) & (USD Million)
    Table 137. South America Psychedelic Drugs Consumption Value by Type (2018-2023) & (USD Million)
    Table 138. South America Psychedelic Drugs Consumption Value by Type (2024-2029) & (USD Million)
    Table 139. South America Psychedelic Drugs Consumption Value by Application (2018-2023) & (USD Million)
    Table 140. South America Psychedelic Drugs Consumption Value by Application (2024-2029) & (USD Million)
    Table 141. South America Psychedelic Drugs Consumption Value by Country (2018-2023) & (USD Million)
    Table 142. South America Psychedelic Drugs Consumption Value by Country (2024-2029) & (USD Million)
    Table 143. Middle East & Africa Psychedelic Drugs Consumption Value by Type (2018-2023) & (USD Million)
    Table 144. Middle East & Africa Psychedelic Drugs Consumption Value by Type (2024-2029) & (USD Million)
    Table 145. Middle East & Africa Psychedelic Drugs Consumption Value by Application (2018-2023) & (USD Million)
    Table 146. Middle East & Africa Psychedelic Drugs Consumption Value by Application (2024-2029) & (USD Million)
    Table 147. Middle East & Africa Psychedelic Drugs Consumption Value by Country (2018-2023) & (USD Million)
    Table 148. Middle East & Africa Psychedelic Drugs Consumption Value by Country (2024-2029) & (USD Million)
    Table 149. Psychedelic Drugs Raw Material
    Table 150. Key Suppliers of Psychedelic Drugs Raw Materials
List of Figures
    Figure 1. Psychedelic Drugs Picture
    Figure 2. Global Psychedelic Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Psychedelic Drugs Consumption Value Market Share by Type in 2022
    Figure 4. Psilocybin
    Figure 5. LSD
    Figure 6. MDMA
    Figure 7. DMT
    Figure 8. Ketamine
    Figure 9. Others
    Figure 10. Global Psychedelic Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 11. Psychedelic Drugs Consumption Value Market Share by Application in 2022
    Figure 12. Depressive Disorders Picture
    Figure 13. Post-Traumatic Stress Disorders Picture
    Figure 14. Substance Abuse Disorders Picture
    Figure 15. Obsessive Compulsive Disorders Picture
    Figure 16. Others Picture
    Figure 17. Global Psychedelic Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 18. Global Psychedelic Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 19. Global Market Psychedelic Drugs Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 20. Global Psychedelic Drugs Consumption Value Market Share by Region (2018-2029)
    Figure 21. Global Psychedelic Drugs Consumption Value Market Share by Region in 2022
    Figure 22. North America Psychedelic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 23. Europe Psychedelic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 24. Asia-Pacific Psychedelic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 25. South America Psychedelic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 26. Middle East and Africa Psychedelic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 27. Global Psychedelic Drugs Revenue Share by Players in 2022
    Figure 28. Psychedelic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 29. Global Top 3 Players Psychedelic Drugs Market Share in 2022
    Figure 30. Global Top 6 Players Psychedelic Drugs Market Share in 2022
    Figure 31. Global Psychedelic Drugs Consumption Value Share by Type (2018-2023)
    Figure 32. Global Psychedelic Drugs Market Share Forecast by Type (2024-2029)
    Figure 33. Global Psychedelic Drugs Consumption Value Share by Application (2018-2023)
    Figure 34. Global Psychedelic Drugs Market Share Forecast by Application (2024-2029)
    Figure 35. North America Psychedelic Drugs Consumption Value Market Share by Type (2018-2029)
    Figure 36. North America Psychedelic Drugs Consumption Value Market Share by Application (2018-2029)
    Figure 37. North America Psychedelic Drugs Consumption Value Market Share by Country (2018-2029)
    Figure 38. United States Psychedelic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 39. Canada Psychedelic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 40. Mexico Psychedelic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 41. Europe Psychedelic Drugs Consumption Value Market Share by Type (2018-2029)
    Figure 42. Europe Psychedelic Drugs Consumption Value Market Share by Application (2018-2029)
    Figure 43. Europe Psychedelic Drugs Consumption Value Market Share by Country (2018-2029)
    Figure 44. Germany Psychedelic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 45. France Psychedelic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 46. United Kingdom Psychedelic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 47. Russia Psychedelic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 48. Italy Psychedelic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 49. Asia-Pacific Psychedelic Drugs Consumption Value Market Share by Type (2018-2029)
    Figure 50. Asia-Pacific Psychedelic Drugs Consumption Value Market Share by Application (2018-2029)
    Figure 51. Asia-Pacific Psychedelic Drugs Consumption Value Market Share by Region (2018-2029)
    Figure 52. China Psychedelic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 53. Japan Psychedelic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 54. South Korea Psychedelic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 55. India Psychedelic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 56. Southeast Asia Psychedelic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 57. Australia Psychedelic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 58. South America Psychedelic Drugs Consumption Value Market Share by Type (2018-2029)
    Figure 59. South America Psychedelic Drugs Consumption Value Market Share by Application (2018-2029)
    Figure 60. South America Psychedelic Drugs Consumption Value Market Share by Country (2018-2029)
    Figure 61. Brazil Psychedelic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 62. Argentina Psychedelic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 63. Middle East and Africa Psychedelic Drugs Consumption Value Market Share by Type (2018-2029)
    Figure 64. Middle East and Africa Psychedelic Drugs Consumption Value Market Share by Application (2018-2029)
    Figure 65. Middle East and Africa Psychedelic Drugs Consumption Value Market Share by Country (2018-2029)
    Figure 66. Turkey Psychedelic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 67. Saudi Arabia Psychedelic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 68. UAE Psychedelic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 69. Psychedelic Drugs Market Drivers
    Figure 70. Psychedelic Drugs Market Restraints
    Figure 71. Psychedelic Drugs Market Trends
    Figure 72. Porters Five Forces Analysis
    Figure 73. Manufacturing Cost Structure Analysis of Psychedelic Drugs in 2022
    Figure 74. Manufacturing Process Analysis of Psychedelic Drugs
    Figure 75. Psychedelic Drugs Industrial Chain
    Figure 76. Methodology
    Figure 77. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

COMPASS Pathways PLC
Pfizer
Eli Lilly
GlaxoSmithKline
Cybin Inc
Field Trip Health
ATAI Life Sciences
NUMINUS WELLNESS
MindMed
HAVN Life Sciences
Seelos Therapeutics
Jannsen
Acadia Pharmaceuticals
Intellipharmaceutics
Revive Therapeutics
Mydecine Innovations Group
Red Light Holland
Braxia Scientific
Mind Cure Health
Entheon Biomedical

Related Reports

Global Psychedelic Drugs Supply, Demand and Key Producers, 2023-2029

Global Psychedelic Drugs Supply, Demand and Key Producers, 2023-2029

date 23 Jan 2023

date Medical Care

The global Psychedelic Drugs market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Psychedelic Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Psychedelic Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 03 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Psychedelic Drugs market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Global Psychedelic Drugs Supply, Demand and Key Producers, 2024-2030

Global Psychedelic Drugs Supply, Demand and Key Producers, 2024-2030

date 29 Feb 2024

date Medical Care

The global Psychedelic Drugs market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Product Tags

Psychedelic Drugs

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>